New facility expected to support expanded cGMP manufacturing of clinical and commercial supply of Company’s pipeline of mRNA cell therapies for the treatment of autoimmune diseases GAITHERSBURG, Md., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results